Navigation Links
Cell Signaling Technology Fosters Discussion of Epigenetic Regulators in Human Disease
Date:8/21/2017

The team at Cell Signaling Technology has arranged for two speakers for this two-part educational webinar, in which attendees will learn about the assembly and topological architecture of mammalian SWI/SNF complexes, cancer-specific complex subunit, and associated protein factor composition. Along with an overview of the development and validation of new high-quality recombinant monoclonal antibodies, participants will learn about the important factors to consider for optimizing different types of target proteins, including histones, transcription factors, and transcription cofactors.

Part one of the webinar will be presented by Dr. Cigall Kadoch, assistant professor of Pediatric Oncology at the Dana-Farber Cancer Institute and Harvard Medical School and an Institute Member of the Broad Institute of MIT and Harvard. She will present studies focused on the assembly and topological architecture of mammalian SWI/SNF complexes, cancer-specific complex subunit and associated protein factor composition, and novel approaches toward the identification of small molecule therapeutics for this class of human tumors.

Kadoch earned her undergraduate degree in molecular and cell biology from the University of California, Berkeley, and a doctorate in cancer biology from the Stanford University School of Medicine. she currently serves as an assistant professor of Pediatric Oncology at the Dana-Farber Cancer Institute and Harvard Medical School and an Institute Member of the Broad Institute of MIT and Harvard. Kadoch studies chromatin regulation, with strong focus on the structure and function of the mammalian SWI/SNF or BAF family of chromatin remodeling complexes in human cancer.

Part two of the webinar will be presented by Dr. Chris Fry, director of Product Development at Cell Signaling Technology. He will provide an overview of the development and validation of new high quality recombinant rabbit monoclonal antibodies that show improved specificity, sensitivity, and reproducibility in ChIP and ChIP-seq assays.

Fry received a Bachelor of Science in biology from Indiana University-Bloomington; later earning a doctorate in oncology from the University of Wisconsin-Madison, where he examined the mechanisms of E2F-mediated gene regulation during G1 and S phases of the mammalian cell cycle. He is currently an associate director of product development at Cell Signaling Technology, where he leads two teams, one that focuses on the development of antibodies against protein and non-protein targets involved in epigenetics, and the other that focuses the development of products for chromatin IP.

LabRoots will host the event September 19, 2017, beginning at 10:30 a.m. PDT, 1:30 p.m. EDT. To learn more about this presentation, discover the continuing education credits offered, or to register for free, click here.

About Cell Signaling Technology
Cell Signaling Technology is a private, family-owned company, founded by scientists and dedicated to providing high-quality research tools to the biomedical research community. The company’s employees operate worldwide from its US headquarters in Massachusetts, and offices in the Netherlands, China, and Japan.

About LabRoots
LabRoots is the leading scientific social networking website, which provides daily scientific trending news, as well as produces educational virtual events and webinars, on the latest discoveries and advancements in science. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Read the full story at http://www.prweb.com/releases/2017/08/prweb14613948.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Review of a New SkinCare Gel that uses Redox Signaling Technology
2. CEDs Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector
3. Study Reports Significant Reduction in Stress via Electrical Neurosignaling
4. Publication in Nature Demonstrates Physiocrine Genetic Mutation Disrupts A Key Signaling Pathway in Neuronal Biology
5. Cell Signaling Technology Releases Four Monoclonal Antibodies for Immunometabolism and Tumor Immunology Research
6. Cell Signaling Technology debuts the CellSimple Cell Analyzer
7. Using Cell Signaling Activity, Rather Than Biomarkers, to Determine the Optimal Therapeutic Regimen for Breast Cancer Patients
8. The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study Results With Cytos Biotechnologys CYT003 for the Treatment of Allergic Asthma
9. Verdad Media’s Unique MANIS Technology Means Better Reputation Management Results for Clients
10. Greenphires ClinCard Technology Platform selected by Bavarian Nordic for Major Vaccine Trial
11. P&P Optica Invited to Cambridge Innovation Centre for the Canadian Technology Accelerator Program, One of Eight Canadian Life Science Companies Chosen to Participate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2019)... ... March 05, 2019 , ... Modality Solutions, an ... filing authorities, logistics network experts, and experienced integrated staffing professionals. , Upon ... Inc. Verified Profile program, Inc. editors independently reviewed the Houston-based cold chain management ...
(Date:2/27/2019)... CALIF. (PRWEB) , ... February 27, 2019 , ... ... its service offering. Starting today, the San Diego-based team-building and cooking events ... people or more: Tacos + Tequila. , This fun-filled, interactive team-building event involves ...
(Date:2/26/2019)... ... February 26, 2019 , ... The ... Dr. Thomas Villani developed the Visikol® tissue clearing technology for improved tissue characterization. ... from a products focused company to primarily a services focused company. , ...
(Date:2/22/2019)... , ... February 20, 2019 , ... Superior Controls, ... IT solutions with 140 employees on both the east and west coasts, today announced ... Manager working out of the company’s Seabrook, New Hampshire office. In his new ...
Breaking Biology Technology:
(Date:2/22/2019)... ... February 21, 2019 , ... Clean label food is ... when creating natural foods and beverages. It is quite common to spot consumers running ... meat products are not immune to this label scrutiny. , More than ever, ...
(Date:2/22/2019)... ... February 21, 2019 , ... The Virginia Commonwealth ... research agreement establishing a collaborative program to work toward applications of Fuzionaire Dx’s ... radiopharmaceutical lead candidates and will explore Fuzionaire Dx’s platform as a unique tool ...
(Date:2/19/2019)... ... February 18, 2019 , ... ... delivery technologies and development solutions for drugs, biologics and consumer health products, ... highest external business partner recognition, the External Business Partner of the Year ...
Breaking Biology News(10 mins):